Gut microbiome and serum metabolome alterations in obesity and after weight-loss interventionOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how the gut microbiome and circulating serum metabolites differ between lean and obese individuals. Researchers used a metagenome-wide association study paired with serum metabolomics profiling to identify obesity-associated gut microbial species and link them to changes in blood metabolites. They further tested a specific microbial species, Bacteroides thetaiotaomicron, in mice to determine its direct effect on body weight and fat accumulation. The study also examined whether bariatric surgery could reverse the microbial and metabolic changes seen in obesity.
Who was studied?
The human portion of the study involved a cohort of lean and obese, young, Chinese individuals, though the abstract does not specify exact sample size. A subset of these obese individuals also underwent bariatric surgery as a weight-loss intervention, with pre- and post-surgery comparisons used to assess reversal of obesity-associated changes. In addition to the human cohort, the researchers used a mouse model to test the functional effects of B. thetaiotaomicron administration via gavage.
What were the most important findings?
The abundance of Bacteroides thetaiotaomicron, a glutamate-fermenting commensal, was markedly decreased in obese individuals and was inversely correlated with serum glutamate concentration. In mice, gavage with B. thetaiotaomicron reduced plasma glutamate concentration and alleviated diet-induced body-weight gain and adiposity. Weight-loss intervention by bariatric surgery partially reversed these obesity-associated microbial and metabolic alterations, including restoring B. thetaiotaomicron abundance and lowering elevated serum glutamate.
What are the greatest implications of this study?
These findings identify a previously unknown link between a specific gut commensal, circulating amino acid levels, and obesity. The inverse relationship between B. thetaiotaomicron and serum glutamate, confirmed functionally in mice, suggests this microbe helps regulate host metabolism through glutamate fermentation. The results suggest it may be possible to intervene in obesity by directly targeting the gut microbiota, offering a potential mechanistic target for future metabolic therapies.